Cardiovascular disease among women with and without diabetes mellitus and bilateral oophorectomy

Diabetes Research and Clinical Practice

Volumn 108, Issue 3, 2015, Pages 473-481

  Appiah, Duke ^a   Winters, Stephen J ^b   Allison, Matthew A ^c   Baumgartner, Richard N ^a   Groves, Frank D ^a   Myers, John A ^a   Hornung, Carlton A ^b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiovascular diseases; Diabetes mellitus; Epidemiology; Women's health

Indexed keywords

GLUCOSE;

ADULT; AGE; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FAMILY HISTORY; FEMALE; GENETIC SUSCEPTIBILITY; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MIDDLE AGED; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARIECTOMY; OVARY; POSTMENOPAUSE; PREVALENCE; RISK REDUCTION; ADVERSE EFFECTS; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COMPLICATION; INCIDENCE; MULTICENTER STUDY; ODDS RATIO; RISK FACTOR; UNITED STATES; WOMEN'S HEALTH;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; ODDS RATIO; OVARIECTOMY; PREVALENCE; RISK FACTORS; UNITED STATES; WOMEN'S HEALTH;

EID: 84930181432     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2015.02.017     Document Type: Article

References (41)

1. Whiteman M.K., Hillis S.D., Jamieson D.J., Morrow B., Podgornik M.N., Brett K.M., et al. Inpatient hysterectomy surveillance in the United States, 2000-2004. Am J Obstet Gynecol 2008, 198. pp. 34.e1-7.
2. Novetsky A.P., Boyd L.R., Curtin J.P. Trends in bilateral oophorectomy at the time of hysterectomy for benign disease. Obstet Gynecol 2011, 118:1280-1286.
3. Parker W.H., Broder M.S., Chang E., Feskanich D., Farquhar C., Liu Z., et al. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study. Obstet Gynecol 2009, 113:1027-1037.
4. Howard B.V., Kuller L., Langer R., Manson J.E., Allen C., Assaf A., et al. Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women's Health Initiative Observational Study. Circulation 2005, 111:1462-1470.
5. Rivera C.M., Grossardt B.R., Rhodes D.J., Brown R.D., Roger V.L., Melton L.J., et al. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause 2009, 16:15-23.
6. Jacoby V.L., Grady D., Wactawski-Wende J., Manson J.E., Allison M.A., Kuppermann M., et al. Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational Study. Arch Intern Med 2011, 171:760-768.
7. Verhoeven M.O., van der Mooren M.J., Teerlink T., Verheijen R.H., Scheffer P.G., Kenemans P. The influence of physiological and surgical menopause on coronary heart disease risk markers. Menopause 2009, 16:37-49.
8. Guthrie J.R., Dennerstein L., Taffe J.R., Lehert P., Burger H.G. The menopausal transition: a 9-year prospective population-based study. The Melbourne Women's Midlife Health Project. Climacteric 2004, 7:375-389.
9. Juutilainen A., Lehto S., Ronnemaa T., Pyorala K., Laakso M. Type 2 diabetes as a coronary heart disease equivalent: an 18-year prospective population-based study in Finnish subjects. Diabetes Care 2005, 28:2901-2907.
10. Ding E.L., Song Y., Malik V.S., Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006, 295:1288-1299.
11. Korytkowski M.T., Krug E.I., Daly M.A., Deriso L., Wilson J.W., Winters S.J. Does androgen excess contribute to the cardiovascular risk profile in postmenopausal women with type 2 diabetes?. Metabolism 2005, 54:1626-1631.
12. Tok E.C., Ertunc D., Evruke C., Dilek S. The androgenic profile of women with non-insulin-dependent diabetes mellitus. J Reprod Med 2004, 49:746-752.
13. Patel S.M., Ratcliffe S.J., Reilly M.P., Weinstein R., Bhasin S., Blackman M.R., et al. Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metabol 2009, 94:4776-4784.
14. Rexrode K.M., Manson J.E., Lee I.M., Ridker P.M., Sluss P.M., Cook N.R., et al. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation 2003, 108:1688-1693.
15. Janssen I., Powell L.H., Kazlauskaite R., Dugan S.A. Testosterone and visceral fat in midlife women: the Study of Women's Health Across the Nation (SWAN) fat patterning study. Obesity (Silver Spring) 2010, 18:604-610.
16. Lambrinoudaki I., Christodoulakos G., Rizos D., Economou E., Argeitis J., Vlachou S., et al. Endogenous sex hormones and risk factors for atherosclerosis in healthy Greek postmenopausal women. Eur J Endocrinol 2006, 154:907-916.
17. Rothman M.S., Carlson N.E., Xu M., Wang C., Swerdloff R., Lee P., et al. Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry. Steroids 2011, 76:177-182.
18. Centers for Disease Control and Prevention (CDC), National Health and Nutrition Examination Survey: Data Survey Overview. National Center for Health Statistics (NCHS).
19. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26(Suppl. 1):S5-S20.
20. Annual update of the HHS poverty guidelines - HHS. Notice 1995, vol. 60:7772-7774. Federal Register.
21. Abramson J.L., Vaccarino V. Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults. Arch Intern Med 2002, 162:1286-1292.
22. Research on the menopause in the 1990. Report of a WHO Scientific Group 1996, vol. 866:1-107. World Health Organization Technical Report Series.
23. Gunther E.W., Lewis B.L. Laboratory procedures used for the Third National Health and Nutrition Examination Survey (NHANES III) 1988-1994 1996, US Department of Health and Human Services, Atlanta, GA.
24. Aziz A., Brannstrom M., Bergquist C., Silfverstolpe G. Perimenopausal androgen decline after oophorectomy does not influence sexuality or psychological well-being. Fertil Steril 2005, 83:1021-1028.
25. Duan L., Xu X., Koebnick C., Lacey J.V., Sullivan-Halley J., Templeman C., et al. Bilateral oophorectomy is not associated with increased mortality: the California Teachers Study. Fertil Steril 2012, 97:111-117.
26. Lamon-Fava S., Herrington D.M., Horvath K.V., Schaefer E.J., Asztalos B.F. Effect of hormone replacement therapy on plasma lipoprotein levels and coronary atherosclerosis progression in postmenopausal women according to type 2 diabetes mellitus status. Metab Clin Exp 2010, 59:1794-1800.
27. Rocca W.A., Grossardt B.R., de Andrade M., Malkasian G.D., Melton L.J. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol 2006, 7:821-828.
28. Jacobson G.F., Shaber R.E., Armstrong M.A., Hung Y.Y. Hysterectomy rates for benign indications. Obstet Gynecol 2006, 107:1278-1283.
29. Shin Y.M., Lee J.K., Turan N., Mauro D., Chong W. Computed tomography appearance of ovarian cysts with hyperenhancing rim during the menstrual cycle in women of different ages. J Comput Assist Tomogr 2010, 34:532-536.
30. Vrbikova J., Grimmichova T., Dvorakova K., Hill M., Stanicka S., Vondra K. Family history of diabetes mellitus determines insulin sensitivity and beta cell function in polycystic ovary syndrome. Physiol Res/Academia Scientiarum Bohemoslovaca 2008, 57:547-553.
31. Vrbikova J., Bendlova B., Vankova M., Dvorakova K., Grimmichova T., Vondra K., et al. Beta cell function and insulin sensitivity in women with polycystic ovary syndrome: influence of the family history of type 2 diabetes mellitus. Gynecol Endocrinol 2009, 25:597-602.
32. Reynolds S.S., Yanek L.R., Vaidya D., Mora S., Moy T.F., Saudek C.D., et al. Glucose levels in the normal range predict incident diabetes in families with premature coronary heart disease. Diabetes Res Clin Pract 2006, 74:267-273.
33. McCarthy A.M., Menke A., Ouyang P., Visvanathan K. Bilateral oophorectomy, body mass index, and mortality in U.S. women aged 40 years and older. Cancer Prev Res (Phila) 2012, 5:847-854.
34. Appiah D., Winters S.J., Hornung C.A. Bilateral oophorectomy and the risk of incident diabetes in postmenopausal women. Diabetes Care 2014, 37:725-733.
35. Nahas E., Pontes A., Traiman P., NahasNeto J., Dalben I., De Luca L. Inhibin B and ovarian function after total abdominal hysterectomy in women of reproductive age. Gynecol Endocrinol 2003, 17:125-131.
36. Davis T.M., Coleman R.L., Holman R.R., Group U. Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79. Circulation 2013, 127:980-987.
37. de Torbal A., Boersma E., Kors J.A., van Herpen G., Deckers J.W., van der Kuip D.A., et al. Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam study. Eur Heart J 2006, 27:729-736.
38. Thompson M.L., Myers J.E., Kriebel D. Prevalence odds ratio or prevalence ratio in the analysis of cross sectional data: what is to be done. Occup Environ Med 1998, 55:272-277.
39. Reichenheim M.E., Coutinho E.S. Measures and models for causal inference in cross-sectional studies: arguments for the appropriateness of the prevalence odds ratio and related logistic regression. BMC Med Res Methodol 2010, 10:66.
40. Phipps A.I., Buist D.S. Validation of self-reported history of hysterectomy and oophorectomy among women in an integrated group practice setting. Menopause 2009, 16:576-581.
41. Ingelsson E., Lundholm C., Johansson A.L., Altman D. Hysterectomy and risk of cardiovascular disease: a population-based cohort study. Eur Heart J 2011, 32:745-750.